Pediatric Antihypertensive Trial Failures: Analysis of Endpoints and Dose Range

Historically, drugs prescribed for children have not been studied in pediatric populations. Since 1997, however, a 6-month extension of marketing rights is granted if manufacturers conduct Food and Drug Administration (FDA)-defined pediatric trials. In nearly half the drugs studied, there were unexp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Benjamin, Daniel K., Smith, P. Brian, Jadhav, Pravin, Gobburu, Jogarao V., Murphy, M. Dianne, Hasselblad, Vic, Baker-Smith, Carissa, Califf, Robert M., Li, Jennifer S.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2782749/
https://ncbi.nlm.nih.gov/pubmed/18332283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.107.108886
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars